Confidence in Concept
Welcome to Imperial Confidence in Concept 2020
Key information
ICiC 2020
Application deadline
Closed
For questions please contact:
Research Strategy Coordinator
Dr Kimberley Trim
confidenceinconcept@imperial.ac.uk
Due to the unusual circumstances we find ourselves in this year, our ICiC scheme has been launched later and without a physical event to showcase translational medical research at Imperial.
However, it remains a key fixture in our innovation and translation armoury, and we are now launching ICiC 2020 online.
ICiC 2020 will enable us to continue to support researchers from across the College by providing pilot funding to establish that your concept has the potential to meet a market need in medicine. We aim to ‘pump-prime’ the translation of research into novel therapeutics, devices and diagnostics - towards clinical testing.
We strongly encourage multi-disciplinary proposals and those including external collaborations - particularly with the Royal Marsden Hospital and our commercial partners AstraZeneca and Yuhan, as well as the Francis Crick Institute or MRC London Institute of Medical Sciences.
ICiC 2020 videos
Prof Ray Hill, Chair of Imperial Confidence
Professor Hill has stepped into the role of Chair after providing excellent support over the past few years as a panel member. Here he talks about key aspects of the current ICiC scheme.
Prof Ray Hill, Chair of Imperial Confidence
Professor Hill talks about key aspects of the current ICiC scheme
Professor Hill has stepped into the role of Chair after providing excellent support over the past few years as a panel member. Here he talks about key aspects of the current ICiC scheme.
Prof Nick Jennings, Vice-Provost (Research and Enterprise)
Professor Jennings welcomes us to the 2020 scheme
Professor Jennings welcomes us to the 2020 scheme and talks about the success of ICiC and translational research at Imperial College London
Dr Pantelis Georgiou, Reader in Biomedical Electronics
Dr Georgiou talks about the impact of ICiC on his research
Dr Georgiou is a successful translational researcher and he has benefited from previous ICiC funding. Here he talks about the impact this has had on his research.
Dr Richard Rutter, Translator in Residence
Dr Rutter talks about his role in helping Imperial researchers
Dr Rutter talks about his role and how he helps Imperial researchers who are navigating the translational landscape. To discuss your ideas for the ICiC scheme, or for broader help around translating your research, please email Dr Rutter (a.rutter@imperial.ac.uk).
Funders
Funding is provided by the Imperial College London Joint Translational Fund, which comprises of generous contributions from:
 |
Imperial College London “One of Imperial’s key strengths is translating exceptional science into real-life applications that have significant societal impact. Through enabling new approaches and disciplines to tacking health problems, ICiC has proven to be vital tool for developing the pipeline for translational research.” - Professor Nick Jennings, Vice-Provost (Research and Enterprise) |
 |
EPSRC Impact Acceleration Account |
 |
MRC Confidence in Concept |
 |
NIHR Imperial Biomedical Research Centre Therapeutic Primer Fund “NIHR Imperial BRC are delighted to support ICiC. This is a vitally important scheme which allows BRC investigators to progress their research and intellectual property further along the translational pipeline to the point where it can be commercialised or evaluated in the clinic.” - Professor Mark Thursz, Director NIHR Imperial BRC |
 |
Rosetrees Trust “Rosetrees Trust is delighted to join with Astra Zeneca, MRC, Wellcome Trust and others to fund outstanding translational research which has a clear path to patient benefit. We wish the researchers success and hope that Rosetrees can continue to fund this initiative for many years to come” - Richard Ross, Chairman of the Rosetrees Trust |
 |
The Royal Marsden Hospital NHS Foundation Trust Fund |
 |
Wellcome Trust Institutional Strategic Support Fund |
 |
AstraZeneca |
|
|
Yuhan |
